ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Intranasal administration of mesenchymal stem cells overexpressing FGF21 demonstrates therapeutic potential in experimental Parkinson's disease.

You-Yen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.